Introduction
Transforming growth factor-b (TGF-b) is a potent inhibitor of proliferation of epithelial, endothelial and hematopoietic cells (reviewed by MassagueÂ , 1990 and Moses et al., 1990) . TGF-b acts by enforcing G 1 -phase arrest of the cell cycle by regulation of activity of cell cycle kinases which target the phosphorylation of the retinoblastoma (pRb) protein (reviewed by Alexandrow and Moses, 1995 and Polyak, 1996) . TGF-b interferes with cell cycle by inhibiting the cyclin dependent kinase (Cdk) activities via regulation of their levels, the kinase inactivating phosphorylations and the abundance of their inhibitors. It induces the synthesis of cyclin dependent kinase inhibitors (CDKI) p15
Ink4b (Hannon and Beach, 1994; Li et al., 1995; Sandhu et al., 1997) and p21
Cip1/Waf1 that bind and inhibit their cognate Cdks, Cdk4/Cdk6 and Cdk2, respectively (reviewed by Sherr and Roberts, 1999) . Eective blocking of the D-type cyclin-Cdk complex is also ensured by TGF-b induced decrease in Cdk4 (Ewen et al., 1993) , and by a rapid decrease in the expression of tyrosine phosphatase Cdc25A, which leads to the inhibitory phosphorylation of Cdk4 and Cdk6 (Iavarone and MassagueÂ , 1997) . TGF-b inactivates also the E-type cyclin-Cdk2 complex (Ko et al., 1993) which manifests by the increased binding of p27 Kip1 (henceforth p27) to the complex, loss of the Cdk2-activating phosphorylation and loss of its kinase activity (Polyak et al., 1994; ReynisdoÂ ttir et al., 1995; Nagahara et al., 1999) . Though TGF-b does not promote p27 synthesis it causes redistribution of p27 from Cdk4/Cdk6-complexes to Cdk2-complexes apparently via induction of p15 (ReynisdoÂ ttir and MassagueÂ , 1997) . The TGF-b antiproliferative action therefore results from inactivation of both G 1 and G 1 /S phase kinases leading to inhibition of pRb phosphorylation (Laiho et al., 1990) and cell cycle arrest.
Cdk6 shares extensive amino acid sequence identity with Cdk4 (Meyerson et al., 1992) , but is preferentially expressed in hematopoietic cells, whereas Cdk4 is ubiquitous in mesenchymal cells (Meyerson et al., 1992) . Both form an active kinase complex with cyclin D (Meyerson and Harlow, 1994) , which additionally requires p27 or p21
Cip1 for full activity (LaBaer et al., 1997; Cheng et al., 1999) . In contrast, the Ink4-family of inhibitors (p15, p16, p18, p19) prevent the catalytic activity of the kinase and favor 1 : 1 stochiometric complexes between Cdk6 and Cdk4 (McConnell et al., 1999; Parry et al., 1999) . Though CDK4 mutations and ampli®cations are found in human tumors (Hall and Peters, 1996) , changes in CDK6 are less frequent, with a mutation in its p16 binding domain found in one neuroblastoma cell line (Easton et al., 1998) , and ampli®cations and translocations found in some gliomas and leukemic cells, respectively, leading to Cdk6 overexpression (Corcoran et al., 1999; Costello et al., 1997) . Cdk4 and Cdk6 share the same substrate, pRb, and target the same sites (Kitagawa et al., 1996) . Mv1Lu mink lung epithelial cells pose an extensively characterized model for TGF-b mediated growth inhibition. The rapid cessation of Mv1Lu cell replication within 12 h (Laiho et al., 1990) correlates by an early induction of p15 and its binding to Cdk4/Cdk6, loss of p27 from cyclin D-complexes and its accumulation to cyclin E-Cdk2-complexes (ReynisdoÂ ttir et al., 1995; ReynisdoÂ ttir and MassagueÂ , 1997) , and pRb conversion to its hypophosphorylated forms (Laiho et al., 1990) . In our previous study we demonstrated that in addition to the above eects of TGF-b on Mv1Lu cells, TGF-b decreases the levels of Cdk6 by inhibiting Cdk6 synthesis and increasing its turnover (Tsubari et al., 1999) . HGF, which eectively abrogates TGF-b antimitogenic activity and forces TGF-b arrested cells to enter the cycle, abrogates the TGF-b induced decrease in Cdk6 and maintains cyclin D-associated kinase activity despite the induction of p15 (Tsubari et al., 1999) . Here we address the signi®cance of Cdk6 and its regulation by TGF-b as a constituent of the TGF-b growth inhibitory circuitry. We show that the decrease in Cdk6 levels parallels the withdrawal of Mv1Lu cells from cycle and that Mv1Lu cells engineered to ectopically express Cdk6 lose TGF-b growth arrest responses. Moreover, transient expression of either Cdk6 or Cdk4, but not Cdk2, rescues the TGF-b arrest of the cells. Collectively, the data support the notion that Cdk6 is an integral partner involved in TGF-b regulation of cell cycle arrest.
Results

Decrease in Cdk6 correlates with TGF-b induced withdrawal of Mv1Lu cells from cycle
We have previously demonstrated that in Mv1Lu cells growth arrested by TGF-b Cdk6 levels are decreased and that this eect is prevented by HGF concomitant with re-entry of the cells into cycle (Tsubari et al., 1999) . Here, we analysed the eect of increasing concentrations of TGF-b on Cdk6 levels and on DNA replication of Mv1Lu cells. To analyse DNA replication, incorporation of 5-BrdU followed by immunostaining was utilized throughout this study because its accuracy is re¯ected in the analysis of DNA replicating cells. The results indicated that TGF-b decreased Cdk6 levels in a dose-dependent manner by up to 75% which correlated the withdrawal of the cells from cycle (62% growth inhibition) ( Figure 1a) . A kinetic experiment showed that a decrease in S phase fraction of the cells correlated with the decline in Cdk6 To further address the relevance of Cdk6 regulation in TGF-b-induced growth arrest of cells, we generated stable Mv1Lu cell lines with ectopic expression of wt Cdk6 or dominant-negative (DN) Cdk6 (van den Heuvel and Harlow, 1993) . The Cdk6-DN harbors a mutation in the ATP-binding site of Cdk6 but does not prevent its interaction with other cellular proteins (van den Heuvel and Harlow, 1993) . In contrast to ectopic expression of Cdk2-DN or Cdk3-DN, Cdk6-DN does not aect cell cycle distribution of human tumor cell lines (van den Heuvel and Harlow, 1993) . Stable Mv1Lu cell lines expressing Cdk6 or Cdk6-DN were generated, which showed approximately 25-fold higher expression of total Cdk6 protein as compared to endogenous Cdk6 present in parental Mv1Lu cells (see Figure 3a for representative clones). The cell cycle distribution of Mv1Lu cells and clones selected for further analysis, Cdk6-DN-3 (DN) and Cdk6-9 (wt), were similar indicating that the ectopic expression of Cdk6 or Cdk6-DN do not confer cell cycle changes (data not shown). DNA replication activity was slightly elevated in Cdk6-9 as compared to Mv1Lu cells (48% vs 41% replication, mean of three independent experiments, Figure 3b ), suggesting that Cdk6 expression led to a slight advantage of DNA replication in agreement with the eect of Cdk6 expression in osteosarcoma cells (Grossel et al., 1999) .
Further analysis of dose-dependent TGF-b growth responses of Cdk6-9 and Cdk6-DN-3 clones in low serum conditions showed that inhibition of DNA replication by TGF-b was clearly attenuated in Cdk6-9 cells as compared with Mv1Lu cells (Figure 2 ). The Cdk6-DN-3 cells responded similarly to the parental Mv1Lu cells (Figure 2 ). We additionally analysed the DNA replication and¯ow cytometric pro®les and TGF-b responses of two additional Cdk6 and two Cdk6-DN clones with respective Cdk6 expression levels to exclude clonal variation. The results demonstrated that these clones were similar to those described above (data not shown). Because the rescue from TGF-b mediated growth arrest by ectopic Cdk6 was partial, and as ectopic expression of Cdk4 has previously been shown to abrogate TGF-b growth arrest (Ewen et al., 1993) , we addressed whether co-expression of both Cdk6 and Cdk4 would fully rescue the TGF-b growth A similar decrease in the nuclear endogenous, but not ectopic Cdk6 was also observed (data not shown). The expression of ectopic Cdk6 was lower in the nuclear fraction as compared to total Cdk6 (12-vs 25-fold), suggesting that a large fraction of ectopic Cdk6 is retained in the cytoplasmic compartment. TGF-b treatment decreased the total level of Cdk4 in all studied clones, though less eciently (Figure 3a) . Analyses for the total levels of two D-type cyclins (cyclin D1 and D2, cyclin D3 is absent in Mv1Lu cells; Ewen et al., 1993) or p27 showed no changes in response to TGF-b in any of the cell lines (Figure 3b) , concordant with previously published data (ReynisdoÂ ttir et al., 1995; ReynisdoÂ ttir and MassagueÂ , 1997; Tsubari et al., 1999) . p15 was induced by TGF-b not only in Mv1Lu cells, but also in the two Cdk6 clones (Figure 3b ), suggesting that an increase in the level of this inhibitor alone is insucient to exert growth arrest. The active form of Cdk2 (fast migrating form, marked as Cdk2-p) was decreased in Mv1Lu and Cdk6-DN cells growth inhibited by TGF-b (Ko et al., 1993; ReynisdoÂ ttir et al., 1995; Tsubari et al., 1999) , whereas there was no change in cyclin E levels ( Figure  3b ). In addition, the results on pRb phosphorylation state were concordant with the growth regulatory responses of TGF-b. Most pRb remained in the slowly migrating phosphorylated forms in the Cdk6-9 cells (Figure 3b ).
p15 is induced in wt Cdk6 cells by TGF-b but D-type kinase activity is not downregulated
Next, we addressed the changes in the composition of the Cdk6-associated protein complexes by immunoprecipitation followed by immunoblotting. In TGF-b treated cells, the induction of p15 leads to its subsequent binding to Cdk4/6 which further facilitates the binding of p27 to the E-type complexes (ReynisdoÂ ttir and MassagueÂ , 1997). Thus, enrichment of p15 bound to Cdk6 by TGF-b was clearly demonstrated in Mv1Lu cells (Figure 4a, second from top) . Interestingly, Cdk6-immunoprecipitations of Cdk6-DN-3 and Cdk6-9 clones followed by p15 immunoblotting showed increased binding of p15 to Cdk6 in the control as well as in the TGF-b treated cells (Figure 4a , second from top). The fold induction of p15 bound to Cdk6 by TGF-b was comparable in the Cdk6 and Cdk6-DN clones (10 ± 13-fold) to that in Mv1Lu cells (15-fold) (Figure 4a ). p27 CDKI is necessary for the assembly and activation of the cyclin D complex (Cheng et al., 1999) , and subject to TGF-b regulation (ReynisdoÂ ttir et al., 1995; ReynisdoÂ ttir and MassagueÂ , 1997) . The levels of p27 bound to either Cdk6 or cyclin D2 were clearly decreased in TGF-b treated Mv1Lu cells, and Cdk6 association to cyclin D2 was lost, re¯ecting the decrease in Cdk6 and probable instability of the complex due to the loss of p27 (Figure 4a ). However, in wt Cdk6 and Cdk6-DN expressing clones, there was no apparent decrease in p27 association with Cdk6 by TGF-b re¯ecting the excess of Cdk6 present in the cells and presumably insucient levels of p15 to fully prevent p27 from binding to Cdk6 (Figure 4a ). Though there were increasing levels of Cdk6 bound to either cyclin D2 or p27 in the ectopic Cdk6 untreated cells, p27 association to cyclin D was not increased (Figure 4a) .
Secondly, we analysed Cdk4 associated protein complexes. In parental Mv1Lu cells, TGF-b treatment decreased Cdk4 association with cyclin D2 and p27 (Figure 4b ) as reported previously (ReynisdoÂ ttir et al., 1995) . Interestingly, there was less cyclin D2 or p27-bound Cdk4 in untreated wt Cdk6 and Cdk6-DN clones, suggesting that the high levels of Cdk6 sequester both cyclin D2 and p27 from the respective Cdk4-complexes (Figure 4b ). In TGF-b-treated Cdk6-9 or Cdk6-DN-3 cells, the decrease in Cdk4 association to cyclin D2 and p27 was of lesser magnitude than in the parental Mv1Lu cells (Figure 4b ), again implicating sequestration of the binding partners by ectopic Cdk6.
To further analyse the relative levels of Cdk4 and Cdk6 aected by TGF-b and their binding to p15, we transiently expressed p15 in Mv1Lu cells, and analysed for p15-associated complexes. After TGF-b treatment, virtually all p15-associated Cdk4 and Cdk6 was absent (Figure 4c ), suggesting that under conditions where p15 is expressed at high levels, its association to both Cdk4 and Cdk6 are lost apparently due to a marked decrease in the respective kinases induced by TGF-b.
To address the regulation of the corresponding kinase activities, we analysed cyclin D2-associated kinase activity using GST-Rb as a substrate. As shown in Figure 4d , the activity of cyclin D2-associated kinase activity was downregulated by TGF-b in both Mv1Lu and Cdk6-DN cells, but only very little in the wt Cdk6 cells. Although the nuclear Cdk6 fraction was ampli®ed over 10-fold in the wt Cdk6 overexpressing cells, the cyclin D2-associated kinase activity was not increased in the untreated Cdk6-9 cells as compared to Mv1Lu cells. This suggests that the increase in Cdk6 alone does not promote kinase activity and that a ratelimiting step exists, which is conferred, e.g. by cyclin D or p27.
Oncogene Cdk6 circumvents TGF-b growth inhibition F Zhang et al Cdk2-associated kinase activity is partially maintained in TGF-b treated wt Cdk6 cells Analysis of Cdk2, cyclin E and p27 complexes showed that about fourfold more p27 was bound to both Cdk2 and cyclin E in Mv1Lu cells (Figure 5a ) (ReynisdoÂ ttir et al., 1995; ReynisdoÂ ttir and MassagueÂ , 1997; Tsubari et al., 1999) . The fraction of p27 complexed either with Cdk2 or cyclin E was also increased in the ectopic Cdk6 clones, but less pronouncedly in the wt Cdk6 clone (Figure 5a ). Since the p27 existing in complexes with Cdk6 in the ectopic Cdk6 clones was not noticeably decreased by TGF-b treatment, p27 relocalized to Cdk2-cyclin E complex appears to be derived from the Cdk4-complex. Concordant to previous publications (ReynisdoÂ ttir et al., 1995; Tsubari et al., 1999) , there was no change in cyclin E association to Cdk2 in the studied clones (Figure 5a ).
To verify whether the increase in p27 in Cdk2-cyclin E complexes is sucient to regulate the Cdk2-kinase activity, we analysed Cdk2-associated kinase activity using histone H1 and GST-Rb as substrates. In all TGF-b treated cells, Cdk2-associated kinase activity towards histone H1 and GST-Rb was downregulated (Figure 5b ). However, there was more GST-Rb kinase activity remaining in the Cdk6 clones, which correlated with the lesser binding of p27 to the Cdk2-cyclin E complex. Concordant to the presence of a higher fraction of replicating cells in the Cdk6-9 cells, the Cdk2-associated kinase activity was higher in the untreated Cdk6-9 cells as compared to Mv1Lu cells (1.2 ± 1.3-fold) (Figure 5b ).
Cdk6 and Cdk4 drive re-entry of TGF-b arrested Mv1Lu cells to S phase
We further wanted to test whether Cdk6, or other Cdks as comparison, can force cell cycle entry in TGFb arrested cells. Mv1Lu cells were treated with TGF-b for 8 h and were then transfected with Cdk expression plasmids, and were further incubated for 40 h in the presence of TGF-b. As control, similar transfections were carried out in untreated Mv1Lu cells. DNA replication was determined by 5-BrdU incorporation, In the case of alternative protein loading, the quantitations were corrected for this factor. (d) Cyclin D2-associated kinase activity was determined by using GST-Rb as substrate. Kinase activities were quantitated by PhosphoImage analyzer, and the kinase activity given by nonimmune serum was subtracted. The decrease in relative activity by TGF-b is shown 
Discussion
In the present study we explore the requirement of Cdk6 downregulation in the TGF-b elicited G 1 -arrest Despite high expression of Cdk6 and the increased binding of p15 and p27 there were minor cell cycle changes in the stable clones. Cdk6-DN clone maintained both cyclin D2-and Cdk2-associated kinase activities at levels comparable to the parental cells despite sequestration of p15 and p27. Though there are gross changes in reorganization of the kinases and their inhibitors in the ectopic clones, a relatively minor level of kinase activity may be sucient for cell cycling or is substituted by Cdk2-associated kinase activities. The eects of ectopic expression of Cdk6 and Cdk6-DN on Mv1Lu cell growth correlate to those by van den Heuvel and Harlow (1993) and Grossel et al. (1999) . Results shown here on Cdk6 regulation are concordant with our ®ndings that an initial event in HGF-mediated release of Mv1Lu cells from TGF-b arrest is inhibition of a decrease in Cdk6 expression (Tsubari et al., 1999) . The data presented here suggest that downregulation of Cdk6 is required for TGF-b to inhibit cyclin D-associated kinase activity and impugns that this occurs only due upregulation of p15. First, the results on the Cdk6-associated complexes in ectopic Cdk6 expressing clones imply that in the parental cells p15, p27 and cyclin D2 exist in excess over Cdk6. The apparent stochiometrically low levels of Cdk6 in parental Mv1Lu cells as compared to either p15, p27 or cyclin D2, suggest that the regulation of its level is particularly vulnerable to the activity of the D-type kinase complex. Therefore, a decrease in Cdk6 level by a factor of two, apparent within 12 h after TGF-b addition, is likely to be crucial in the initiation and/ or maintenance of the G 1 -arrest of the cells. Moreover, simultaneous induction and binding of p15 to Cdk6 ensures that all residual Cdk6 is blocked. Second, in cells with transient, high level expression of p15, p15-associated Cdk4 and Cdk6 complexes were dramatically decreased upon TGF-b treatment. In consequence, the binding of p15 to the residual Cdk6 prevents p27 interaction to Cdk6-cyclin D complexes causing its association to Cdk2-cyclin E complex. Thus, the decrease in Cdk6 serves an early and important step which ensures that both D-and E-type cyclin kinase complexes are inactivated. The ®ndings identify the regulation of Cdk6 as an essential element in this process and therefore clearly extend the model presented by ReynisdoÂ ttir et al. (1995); and ReynisdoÂ ttir and MassagueÂ (1997) suggesting the eect originating solely of p15 regulation.
Assaying for D-and E-type complex activities in the wt Cdk6 expressing cells showed that TGF-b did not compromise cyclin D2-associated kinase activity. However, it decreased Cdk2-associated kinase activity by 40 ± 70% which correlated with the increased binding of p27 to both Cdk2 and cyclin E. Yet, the Cdk2 kinase activity was retained at a higher level in the wt Cdk6 cells than in the parental cells. This appears to be due to a higher basal kinase activity and to lesser binding of p27 to Cdk2-cyclin E complex in the wt Cdk6 cells as shown in Figure 5b . As p27 appears not to be released from the ectopic Cdk6, its increased binding to Cdk2 re¯ects its relocalization from Cdk4. In consequence, in the wt Cdk6 clone, the TGF-b induced arrest is compromized through unrestricted cyclin D-associated kinase activity and partially maintained cyclin E-associated kinase activity. Possibly because a fraction of cyclin E-associated kinase activity is still downregulated, the wild-type Cdk6 clone cannot fully escape from the TGF-b growth inhibition. Alternatively, Cdk2-activity is regulated also by other means besides through regulation by p27 as suggested by studies by Nagahara et al. (1999) .
Ectopic expression of the kinase negative Cdk6 serves here as an important control. Similar to wt Cdk6, the presence of high levels of DN-Cdk6 leads to its increased binding to p15 and p27. In spite of this, the Cdk6-kinase activity is inhibited to a similar extent as in the parental cells. Therefore, the induction of TGF-b arrest in the DN clone and lack of it in wt clone cannot be explained only by the high levels of either wt or DN Cdk6 sequestering Cdk inhibitors, but also by the presence of an active kinase in the former and an inactive in the latter.
Interfering with the RB-pathway has dierent degrees of severity in blocking TGF-b antimitogenic eects. Full abrogation of TGF-b arrest pathway has been achieved in Mv1Lu cells by blocking pRB function by SV40 large T antigen (Laiho et al., 1990) , but also by expression of Myc (Warner et al., 1999) . On the other hand, ectopic expression of Cdk4, Cdk6 or E2F lead to only partial release of the arrest (Ewen et al., 1993; Schwartz et al., 1995) . Here we found no evidence that co-expression of Cdk4 and Cdk6 would fully alleviate the TGF-b induced arrest. Genetic evidence strongly suggests that p27 or p15 alone are not sucient to confer cell cycle arrest by TGF-b, as TGF-b induces arrest in cells derived from either p27 (Nakayama et al., 1996) or p15 knock-out animals (Latres et al., 2000) . This is also supported by the lack of growth arrest by Cdk6-DN sequestration of p15. In light of these, the full abrogation achieved by Myc via bypassing p15 induction (Warner et al., 1999) is surprising, and implies that Myc may target additional molecules in the Cdk-cyclin cascades. Interestingly, introduction of either Cdk6 or Cdk4 into TGF-b arrested Mv1Lu cells forced cell cycle re-entry, suggesting that a transient burst of a G 1 -phase kinase could eectively bypass the arrest. The present ®ndings provide ®rm evidence placing the regulation of Cdk6 as an important constituent of the TGF-b antimitogenic eects.
Cdk6 circumvents TGF-b growth inhibition F Zhang et al
Materials and methods
Cells, cell culture and transfections
Mv1Lu mink lung epithelial cells (CCL64, ATCC) were maintained in DMEM supplemented with 10% fetal calf serum (FCS). Cells were maintained at 5% CO 2 atmosphere at 378C. Cdk6 and Cdk6-DN overexpressing stable cell lines were generated by transfecting Mv1Lu cells with expression constructs for Cdk6 and Cdk6-DN (Cdk6/pRC-CMV and Cdk6-DN/pRC-CMV, respectively, obtained from Ed Harlow, Massachusetts General Hospital Cancer Center) together with neomycin resistance plasmid by calcium phosphate precipitation. Stable transfectants were selected, isolated and analysed for Cdk6 expression. As judged by immunouorescence, the staining for Cdk6 was homogenous in these clones (80 ± 90% positive cells) with both nuclear and cytoplasmic localizations. For transient transfection, Mv1Lu cells were treated with 100 pM TGF-b for 8 h, and were transfected with 5 mg of the indicated human Cdk expression vectors combined with 5 mg carrier plasmid by calcium phosphate precipitation. Alternatively, Mv1Lu cells were transfected with p15 expression vector (p15pSG5, Tsubari et al., 1997) , followed by TGF-b treatment. In all assays, unless otherwise noted, the cells were incubated with 100 pM TGF-b in DMEM containing 10% of FCS for 16 h. TGF-b was puri®ed from outdated human platelets.
Antibodies
Antibodies used for immunoblotting of Cdk2 (M2), Cdk4 (C-22), Cdk6 (C-21), cyclin D1 (H-295), cyclin D2 (C-17), cyclin E (M-20), p15 (C-20), p27 (C-19) and pRb (C-15) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies used for immunoprecipitation were as above except for cyclin E (06 ± 459, Upstate Biotechnology, Lake, NY, USA) and Cdk4 (Ab-1, Neomarkers, Fremont, CA, USA). Biotin-conjugated goat anti-rabbit and goat anti-mouse antibodies were from DAKO (Glostrup, Denmark).
5-BrdU and immunofluorescence staining
Cells grown on glass coverslips were incubated with 50 mM 5-bromo-2'-deoxyuridine (5-BrdU, Amersham Life Sciences, Amersham, UK) for 1 h and ®xed with 3.5% paraformaldehyde (PFA) in PBS for 20 min at room temperature. Cells were permeabilized with 0.5% Nonidet P-40 (NP-40) in PBS and DNA was denatured with 1.5 M HCl. Replicating nuclei were detected by staining with monoclonal anti-5-BrdU antibody (Amersham) followed by rhodamine-conjugated rabbit anti-mouse antibody (DAKO, Denmark). Nuclei were counterstained with Hoechst 33258 (Sigma). For each experiment over 200 nuclei were analysed. For double immunostaining of Cdks and 5-BrdU, cells were incubated with the indicated polyclonal antibody against Cdk and monoclonal anti-5-BrdU antibody, and then stained with FITC-conjugated goat anti-mouse antibody (Sigma), followed by TRITC-conjugated swine anti-rabbit antibody (DAKO). The staining was visualized with Axioplan 2 MOT microscope (Zeiss) equipped with appropriate ®lters.
Immunoblotting
Total cell lysates were prepared exactly as described before (Tsubari et al., 1999) , followed by determination of protein concentrations by Bradford assay. Alternatively, cells were lysed in 25 mM Tris-HCl buer, pH 8.0, containing 120 mM NaCl, 0.5% NP-40, 4 mM NaF, 100 mM Na 3 VO 4 , 100 KIU/ ml aprotinin, 1 mM phenylmethylsulfonyl¯uoride (PMSF) and 10 mg/ml leupeptin followed by determination of protein concentrations by Bio-Rad DC Protein assay (Bio-Rad). Total cellular proteins (20 mg) were separated by SDS-polyacrylamide gels electrophoresis (PAGE) and were transferred to Immobilon-P membranes (Millipore, Bradford, MA, USA.). Immunoblotting with the indicated antibodies was carried out as described before (Tsubari et al., 1999) followed by detection with enhanced chemiluminescence (Amersham Life Sciences). For analyses of ectopically expressed Cdk6 levels in Cdk6-9 and Cdk6-DN-3 cells, 2 mg of total proteins were analysed. Several chemiluminescence exposures were developed and the signals were quantitated by Multi-Analyst program 1.0.1 (Bio-Rad) with background subtraction.
Immunoprecipitation
For immunoprecipitation, cells were washed by ice-cold PBS and incubated with NP-40 lysis buer (50 mM Tris-HCl, pH 7.5, containing 150 mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and 0.1 mg/ml each leupeptin, E-64, and SBTI) for 20 min at 48C and protein concentrations were measured by BioRad DC Protein assay. Cell extracts normalized for the protein concentrations were precleared with GammaBind G-Sepharose (Pharmacia Biotech, Sweden) and supernatants were precipitated with 0.5 mg of indicated antibodies. The immunocomplexes were collected by GammaBind G-Sepharose and were extensively washed with NP-40 lysis buer. Precipitates (15 ml) were separated by SDS ± PAGE and immunoblotting was carried out as described above.
Kinase assays
Kinase analyses were carried out as described before (Tsubari et al., 1999) . To detect Cdk2-associated kinase activity cells were lysed with NP-40 lysis buer as above, and for cyclin Dassociated kinase activity cells were lysed to a modi®ed lysis buer according to Matsushime et al. (1994) . After immunoprecipitation and washes, the kinase reaction was carried out in kinase buer (50 mM HEPES-KOH, pH 7.5, 10 mM MgCl, 1 mM DTT, 2.5 mM EGTA, 0.1 mM sodium orthovanadate, 1 mM NaF, 20 mM ATP, and 10 mCi [l- 
